Effects of the Proteasome Inhibitor Bortezomib in Combination with Chemotherapy for the Treatment of Mantle Cell Lymphoma: A Meta-analysis

Effects of the Proteasome Inhibitor Bortezomib in Combination with Chemotherapy for the Treatment of Mantle Cell Lymphoma: A Meta-analysis

Objective: The efficacy and the safety of bortezomib-based chemotherapy were characterized in mantle cell lymphoma (MCL) patients. Materials and Methods: The PubMed, Cochrane Library, Clinical Key, Science Direct, Oxford Journals, and China National Knowledge Internet databases were searched up to...

Full description

Bibliographic Details
Main Authors:	Shi-jun Li, Jian Hao, Yu Mao, Yu-ling Si
Format:	Article
Language:	English
Published:	Galenos Publishing House 2020-02-01
Series:	Turkish Journal of Hematology
Subjects:	bortezomib chemotherapy mantle cell lymphoma metaanalysis
Online Access:	https://jag.journalagent.com/z4/download_fulltext.asp?pdir=tjh&un=TJH-70094

Similar Items

Cyclin D1-CDK4 activity drives sensitivity to bortezomib in mantle cell lymphoma by blocking autophagy-mediated proteolysis of NOXA
by: Simon Heine, et al.
Published: (2018-09-01)

Synergistic suppression of the PI3K inhibitor CAL-101 with bortezomib on mantle cell lymphoma growth
by: Fu-Lian Qu, et al.
Published: (2015-12-01)

Combined therapy with ibrutinib and bortezomib followed by ibrutinib maintenance in relapsed or refractory mantle cell lymphoma and high-risk features: a phase 1/2 trial of the European MCL network (SAKK 36/13)Research in context
by: Urban Novak, et al.
Published: (2023-10-01)

Multi-center phase II trial of bortezomib and rituximab maintenance combination therapy in patients with mantle cell lymphoma after consolidative autologous stem cell transplantation
by: Robert W. Chen, et al.
Published: (2018-06-01)

Homoharringtonine interacts synergistically with bortezomib in NHL cells through MCL-1 and NOXA-dependent mechanisms
by: Tri Nguyen, et al.
Published: (2018-11-01)

Mantle Zone Cell Lymphomas. New Opportunities for Diagnosis and Treatment (Epidemiological Research)
by: E. I. Kankumasheva, et al.
Published: (2020-01-01)

cutaneous manifestation of mantle cell lymphoma
by: avinash kumar singh, et al.
Published: (2014-08-01)

Proteasome inhibitors prevent tumor cell proliferation in HHV-8-unrelated PEL-like lymphoma
by: Kiyotaka Kawauchi, et al.
Published: (2025-01-01)

Pulmonary mantle cell lymphoma: a rare manifestation of an uncommon condition
by: Zachary S. DePew, et al.
Published: (2012-02-01)

Cutaneous involvement by a mantle cell lymphoma
by: Ana G. Lopes, et al.
Published: (2023-07-01)

Proteasome inhibitor bortezomib prevents proliferation and migration of pulmonary arterial smooth muscle cells
by: Yi‐Ching Liu, et al.
Published: (2024-06-01)

Petechial, purpuric, and ecchymotic presentation of cutaneous Cryptococcus in mantle cell lymphoma
by: Christie D. Kimball, BS, et al.
Published: (2017-01-01)

Mantle Cell Lymphoma Presenting with Acute Bilateral Ophthalmoplegia
by: Yaran Koban, et al.
Published: (2017-08-01)

The Clinical Impact of Precisely Defining Mantle Cell Lymphoma: Contributions of Elaine Jaffe
by: Mark Roschewski, et al.
Published: (2022-08-01)

Mantle Cell Lymphoma Presenting as a Subcutaneous Mass of the Right Leg
by: Drew A. Fajardo, et al.
Published: (2020-07-01)

Bortezomib Amplifies Effect on Intracellular Proteasomes by Changing Proteasome Structure
by: David S. Pitcher, et al.
Published: (2015-07-01)

Bortezomib, Lenalidomide and Dexamethasone Combination Induced Complete Remission in Relapsed/Refractory Plasmablastic Lymphoma: Case Report of a Potential Novel Treatment Approach
by: Waleed Sabry, et al.
Published: (2022-07-01)

Colonic lymphomatous polyposis mantle cell lymphoma: a case report and review of literature
by: Toukilnan Djiwa, et al.
Published: (2024-05-01)

Chylous Ascites due to Mantle Cell Lymphoma
by: Ricardo Jorge Gonçalves Fernandes, et al.
Published: (2018-04-01)

Skin Manifestations associated with Mantle cell Lymphoma: a case report
by: avinash kumar singh, et al.
Published: (2013-02-01)

Mantle Cell Lymphoma of Intestine Presenting as Multiple Lymphomatous Polyposis with Intussusception
by: Meena N. Jadhav, et al.
Published: (2015-01-01)

Primary gastric mantle cell lymphoma
by: Duska Petranovic, et al.
Published: (2012-01-01)

FDG-PET in mantle cell lymphoma involving skin
by: Mehmet Sönmez, et al.
Published: (2010-12-01)

Cutaneous lesions as presentation form of mantle cell lymphoma
by: Nayra Merino de Paz, et al.
Published: (2011-12-01)

Treatment of mantle cell lymphoma in Asia: a consensus paper from the Asian Lymphoma Study Group
by: Dok Hyun Yoon, et al.
Published: (2020-03-01)

Novel BRAF N581S mutation in mantle cell lymphoma
by: Nisha Hariharan, et al.
Published: (2024-02-01)

Proteasome subunit expression analysis and chemosensitivity in relapsed paediatric acute leukaemia patients receiving bortezomib-containing chemotherapy
by: Denise Niewerth, et al.
Published: (2016-09-01)

Bortezomib, lenalidomide, and dexamethasone versus bortezomib, doxorubicin, and dexamethasone in newly diagnosed multiple myeloma
by: Dong Liang, et al.
Published: (2024-09-01)

Case report: Composite mantle cell lymphoma and classical Hodgkin lymphoma
by: Hongyu Wang, et al.
Published: (2023-03-01)

A clinicopathologic study of mantle cell lymphoma in a single center study in India
by: Gujral S, et al.
Published: (2008-07-01)

Mantle Cell Lymphoma Presenting as Multiple Lymphomatous Polyposis of the Colon
by: Syed Shafiq, et al.
Published: (2020-06-01)

In situ Electrochemical Evaluation of the Interaction of dsDNA with the Proteasome Inhibitor Anticancer Drug Bortezomib
by: Mihaela-Cristina Bunea, et al.
Published: (2023-04-01)

Mantle cell lymphoma and involvement of lacrimal glands and orbit
by: E.V. Vilchevskaia, et al.
Published: (2016-04-01)

Bilateral mantle cell lymphoma of the ciliary body that responded to a combined local radiotherapy and chemotherapy regimen: a case report
by: Minghang Pei, et al.
Published: (2019-04-01)

Dihydroorotate dehydrogenase inhibition acts synergistically with tyrosine kinase inhibitors to induce apoptosis of mantle cell lymphoma cells
by: May Eriksen‐Gjerstad, et al.
Published: (2022-08-01)

Mantle cell lymphoma: A clinical review of the changing treatment paradigms with the advent of novel therapies, and an insight into Indian data
by: Vivek Sulekha Radhakrishnan, et al.
Published: (2022-07-01)

Ferroptosis-related prognostic model of mantle cell lymphoma
by: Gao Qianwen, et al.
Published: (2024-11-01)

Diagnosis and treatment of mantle cell lymphoma
by: Felicitas Hitz, et al.
Published: (2013-11-01)

Challenges in the diagnostics of mantle cell lymphoma in an elderly comorbid patient
by: Rostislav V. Binyakovskiy, et al.
Published: (2024-11-01)

The HB22.7 Anti-CD22 monoclonal antibody enhances bortezomib-mediated lymphomacidal activity in a sequence dependent manner
by: Martin Shiloh M, et al.
Published: (2011-12-01)